Concentration-dependent effect of abciximab on platelets and neutrophils in a model of cardiopulmonary bypass

Abciximab is a GPIIb/IIIa antagonist used in percutaneous coronary interventions to avoid platelet activation, thrombosis and inflammation. We investigated w...